Cyclosporine and graft coronary artery disease after heart transplantation

Compr Ther. 2000 Summer;26(2):121-6. doi: 10.1007/s12019-000-0022-9.

Abstract

Risk factors for graft coronary artery disease after heart transplant are discussed in relationship to cyclosporine dosages. Patients receiving a mean cyclosporine dose higher than 4 mg/kg/day had lower incidence of graft coronary disease than patients receiving lower dosages.

Publication types

  • Review

MeSH terms

  • Coronary Disease / epidemiology
  • Coronary Disease / prevention & control*
  • Cyclosporine / therapeutic use*
  • Graft Rejection / epidemiology
  • Graft Rejection / prevention & control*
  • Heart Transplantation* / mortality
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Incidence
  • Risk Factors

Substances

  • Immunosuppressive Agents
  • Cyclosporine